Literature DB >> 9828718

Pathophysiology of bile duct stones.

J L Thistle1.   

Abstract

Secondary duct stones are usually detected and easily removed at the time of cholecystectomy either during surgery or endoscopically before or after the operation. Primary duct stone diseases, although much less common, are often a greater therapeutic challenge. These stones may be huge, distributed throughout the biliary tree (including areas difficult to access), and unresponsive to pharmacologic measures. Recurrence of primary duct stones is the rule rather than the exception, and reliable methods for prevention remain to be established. Moreover, morbidity and mortality due to biliary obstruction, sepsis, and choliangiocarcinoma make primary bile duct stone disease a formidable adversary. A better understanding of their pathogenesis can facilitate more effective approaches to treatment and, most important, prevention.

Entities:  

Mesh:

Year:  1998        PMID: 9828718     DOI: 10.1007/s002689900529

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  4 in total

1.  Does the bile duct angulation affect recurrence of choledocholithiasis?

Authors:  Dong Beom Seo; Byoung Wook Bang; Seok Jeong; Don Haeng Lee; Shin Goo Park; Yong Sun Jeon; Jung Il Lee; Jin-Woo Lee
Journal:  World J Gastroenterol       Date:  2011-09-28       Impact factor: 5.742

2.  Operative management of recurrent choledocholithiasis.

Authors:  Kazuhide Matsushima; David I Soybel
Journal:  J Gastrointest Surg       Date:  2012-08-21       Impact factor: 3.452

3.  Biliary metal stent as a nidus for bile duct stone.

Authors:  Young Koog Cheon; Jong Ho Moon; Young Deok Cho; Yun Soo Kim; Moon Sung Lee; Chan Sup Shim
Journal:  Korean J Intern Med       Date:  2002-03       Impact factor: 2.884

4.  A common bile duct stone formed by suture material after open cholecystectomy.

Authors:  Kook-Hyun Kim; Byung-Ik Jang; Tae-Nyeun Kim
Journal:  Korean J Intern Med       Date:  2007-12       Impact factor: 3.165

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.